Physician profile
Ann M Prejs
NPI 1497365480
$2,204.31
in general payments reported to CMS, 2019-2025
28 companies · $1,572 in 2025
The $1,572 reported for 2025 was more than what 93% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $280 · 2022: $13.31 · 2024: $339 · 2025: $1,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,381 · Travel and Lodging: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.53 |
| Travel and Lodging | $530.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $884.04 | 2025 | Barostim Neo System |
| Astellas Pharma US INC | $265.92 | 2021-2024 | Xtandi |
| E.R. Squibb & Sons, L.L.C. | $154.48 | 2024-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $140.10 | 2025 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.42 | 2024-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $99.35 | 2024-2025 | Uptravi, Opsynvi, Opsumit |
| Kestra Medical Technology Services, INC. | $73.21 | 2024 | Assure Wcd |
| Imperative Care, INC | $69.54 | 2025 | Prodigy Catheter, Symphony Catheter, Prodigy Twist |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.19 | 2025 | Lifevest |
| Esperion Therapeutics, INC. | $33.59 | 2024-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $29.49 | 2025 | |
| Medtronic, INC. | $26.85 | 2021 | |
| Philips North America LLC | $25.59 | 2025 | Lm Accessories |
| Chiesi USA, INC. | $21.72 | 2025 | Juxtapid |
| Novartis Pharmaceuticals Corporation | $19.99 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $19.00 | 2025 | Evkeeza |
| Atricure, INC. | $18.84 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| United Therapeutics Corporation | $17.89 | 2024 | Tyvaso |
| Bridgebio Pharma, INC. | $17.65 | 2025 | Attruby |
| Silk Road Medical, INC. | $17.08 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Kiniksa Pharmaceuticals International, Plc | $17.00 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $16.23 | 2024 | |
| Pfizer INC. | $16.20 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $16.11 | 2024 | |
| Amgen INC. | $15.79 | 2024 | Repatha |
| Agepha Pharma Fz LLC | $15.36 | 2025 | Lodoco |
| Acacia Pharma INC | $14.99 | 2021 | |
| Abiomed | $13.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Prejs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.